Search
for

    Sort by

    Research 301–330 of 1000+

    1. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer Journal of oncology pharmacy practice · 2016 · 19 citations
    2. Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy Journal of Immunotherapy · 2023 · 2 citations
    3. Cutaneous lupus erythematosus induced by tislelizumab JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024 · 1 citations
    4. Cemiplimab-Induced Alopecia Areata International Journal of Trichology · 2023
    5. Pembrolizumab-Induced Autoimmune Hepatitis ˜The œAmerican journal of gastroenterology · 2018
    6. Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy JAAD Case Reports · 2024 · 2 citations
    7. Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description JAAD Case Reports · 2021 · 12 citations
    8. 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies Journal of Investigative Dermatology · 2024
    9. Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023 Frontiers in Immunology · 2024 · 1 citations
    10. 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis Journal of Investigative Dermatology · 2019
    11. Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling. Journal of Clinical Oncology · 2026
    12. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy Journal of the American Academy of Dermatology · 2018 · 32 citations
    13. Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system Frontiers in Medicine · 2026
    14. Anais do II Congresso Nacional Acadêmico de Dermatologia 2022
    15. ES01.01 Chemotherapy is Strictly Additive to Immunotherapy Journal of Thoracic Oncology · 2019 · 1 citations
    16. Editors’ Picks Journal of Investigative Dermatology · 2022
    17. Internal peacekeepers and external mediators: A new model of peripheral immune tolerance involving regulatory T cells and mesenchymal stem cells Advances in Clinical and Experimental Medicine · 2026
    18. Immunohistochemical Pattern of CD34 Distribution in Different Types of Basal Cell Carcinoma and in Peritumoral Skin Medicina · 2026
    19. Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues Bioscience Reports · 2022 · 2 citations
    20. 496 Evaluation of extracts containing red clover using dermal papilla cells in the development of a scalp treatment system targeting hair loss and hair damage Journal of Investigative Dermatology · 2020
    21. МИКРОБИОЦЕНОЗ ЛУНОК УДАЛЕННЫХ ЗУБОВ У ПАЦИЕНТОВ С АЛЬВЕОЛИТОМ Голова и шея. · 2022 · 1 citations
    22. DETERMINATION OF THE DEGREE OF TISSUE HEATING UNDER THE EXPOSURE TO LASER RADIATION WITH A WAVELENGTH OF 445±40 NM Голова и шея. · 2022
    23. Aesthetic medicine treatments for oncology patients — a narrative literature review Nowotwory Journal of Oncology · 2026
    24. Farmácia Avenida - Guimarães e nos Serviços Farmacêuticos da Unidade Local de Saúde do Alto Ave, EPE - Guimarães Open Repository of the University of Porto (University of Porto) · 2025
    25. Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras Revista médica hondureña · 2023
    26. Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines Pharmaceutics · 2023 · 1 citations
    27. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    28. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study Cancers · 2023 · 1 citations
    29. Survey on adverse events associated with drug therapy for breast cancer patients BMC Women s Health · 2024 · 7 citations
    30. Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine Skin Appendage Disorders · 2025